{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T12:54:52Z","timestamp":1791291292509,"version":"4.3.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T00:00:00Z","timestamp":1784937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:00:00Z","timestamp":1791244800000},"content-version":"vor","delay-in-days":73,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Digit. Med."],"DOI":"10.1038\/s41746-026-03012-7","type":"journal-article","created":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T06:54:58Z","timestamp":1784962498000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Digital decision support using a phospholipid-dependent biomarker for early exclusion of negative cases in lupus anticoagulant diagnostics"],"prefix":"10.1038","volume":"9","author":[{"given":"Khen","family":"Khermesh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaniv","family":"Alon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roi","family":"Gatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Shalev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanya","family":"Badelbayev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifat","family":"Alcalay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Varda","family":"Deutsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilia","family":"Kirgner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mor","family":"Saban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben-Zion","family":"Katz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,25]]},"reference":[{"key":"3012_CR1","doi-asserted-by":"publisher","first-page":"e32001","DOI":"10.1371\/journal.pone.0032001","volume":"7","author":"KH Ching","year":"2012","unstructured":"Ching, K. H. et al. Two major autoantibody clusters in systemic lupus erythematosus. PLoS ONE 7, e32001 (2012).","journal-title":"PLoS ONE"},{"key":"3012_CR2","doi-asserted-by":"publisher","first-page":"S75","DOI":"10.1002\/ajh.23196","volume":"87","author":"TL Ortel","year":"2012","unstructured":"Ortel, T. L. Antiphospholipid syndrome: laboratory testing and diagnostic strategies. Am. J. Hematol. 87, S75\u2013S81 (2012).","journal-title":"Am. J. Hematol."},{"key":"3012_CR3","doi-asserted-by":"publisher","first-page":"2828","DOI":"10.1111\/jth.15047","volume":"18","author":"KMJ Devreese","year":"2020","unstructured":"Devreese, K. M. J. et al. Guidance from the Scientific and Standardization Committee for lupus anticoagulant\/antiphospholipid antibodies of the International Society on Thrombosis and Haemostasis. J. Thromb. Haemost. 18, 2828\u20132839 (2020).","journal-title":"J. Thromb. Haemost."},{"key":"3012_CR4","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1002\/art.42624","volume":"75","author":"M Barbhaiya","year":"2023","unstructured":"Barbhaiya, M. et al. The 2023 ACR\/EULAR antiphospholipid syndrome classification criteria. Arthritis Rheumatol 75, 1687\u20131702 (2023).","journal-title":"Arthritis Rheumatol"},{"key":"3012_CR5","doi-asserted-by":"publisher","first-page":"157","DOI":"10.2217\/ijr.11.9","volume":"6","author":"BE Harper","year":"2011","unstructured":"Harper, B. E., Wills, R. & Pierangeli, S. S. Pathophysiological mechanisms in antiphospholipid syndrome. Int. J. Clin. Rheumatol. 6, 157\u2013171 (2011).","journal-title":"Int. J. Clin. Rheumatol."},{"key":"3012_CR6","doi-asserted-by":"publisher","first-page":"4714","DOI":"10.1182\/blood-2011-03-340232","volume":"118","author":"V Pengo","year":"2011","unstructured":"Pengo, V. et al. Incidence of a first thromboembolic event in asymptomatic carriers of high-risk antiphospholipid antibody profile: a multicenter prospective study. Blood 118, 4714\u20134718 (2011).","journal-title":"Blood"},{"key":"3012_CR7","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1111\/j.1538-7836.2009.03555.x","volume":"7","author":"V Pengo","year":"2009","unstructured":"Pengo, V. et al. Update of the guidelines for lupus anticoagulant detection. J. Thromb. Haemost. 7, 1737\u20131740 (2009).","journal-title":"J. Thromb. Haemost."},{"key":"3012_CR8","unstructured":"Feinstein, D. I. & Rapaport, S. I. Acquired inhibitors of blood coagulation. In Progress in Hemostasis and Thrombosis Vol. 1 (ed. Spaet, T. H.) 75\u201395 (Grune & Stratton, New York, 1972)."},{"key":"3012_CR9","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1111\/jth.13976","volume":"16","author":"KMJ Devreese","year":"2018","unstructured":"Devreese, K. M. J. et al. Laboratory criteria for antiphospholipid syndrome: communication from the SSC of the ISTH. J. Thromb. Haemost. 16, 809\u2013813 (2018).","journal-title":"J. Thromb. Haemost."},{"key":"3012_CR10","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1056\/NEJMra1705454","volume":"378","author":"D Garcia","year":"2018","unstructured":"Garcia, D. & Erkan, D. Diagnosis and management of the antiphospholipid syndrome. N. Engl. J. Med. 378, 2010\u20132021 (2018).","journal-title":"N. Engl. J. Med."},{"key":"3012_CR11","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1111\/jth.14846","volume":"18","author":"A Tripodi","year":"2020","unstructured":"Tripodi, A., Cohen, H. & Devreese, K. M. J. Lupus anticoagulant detection in anticoagulated patients: guidance from the Scientific and Standardization Committee for lupus anticoagulant\/antiphospholipid antibodies of the International Society on Thrombosis and Haemostasis. J. Thromb. Haemost. 18, 1569\u20131575 (2020).","journal-title":"J. Thromb. Haemost."},{"key":"3012_CR12","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1002\/rth2.12264","volume":"4","author":"PMM De Kesel","year":"2020","unstructured":"De Kesel, P. M. M. & Devreese, K. M. J. The effect of unfractionated heparin, enoxaparin, and danaparoid on lupus anticoagulant testing: can activated carbon eliminate false-positive results? Res. Pract. Thromb. Haemost. 4, 161\u2013168 (2020).","journal-title":"Res. Pract. Thromb. Haemost."},{"key":"3012_CR13","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1182\/hematology.2021000241","volume":"2021","author":"KA Moser","year":"2021","unstructured":"Moser, K. A. & Smock, K. J. Direct oral anticoagulant interference in hemostasis assays. Hematology Am. Soc. Hematol. Educ. Program 2021, 129\u2013133 (2021).","journal-title":"Hematology Am. Soc. Hematol. Educ. Program"},{"key":"3012_CR14","doi-asserted-by":"publisher","first-page":"2164","DOI":"10.3390\/jcm11082164","volume":"11","author":"A Vandevelde","year":"2022","unstructured":"Vandevelde, A. & Devreese, K. M. J. Laboratory diagnosis of antiphospholipid syndrome: insights and hindrances. J. Clin. Med. 11, 2164 (2022).","journal-title":"J. Clin. Med."},{"key":"3012_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1600-0609.2009.01243.x","volume":"83","author":"K Devreese","year":"2009","unstructured":"Devreese, K. & Hoylaerts, M. F. Laboratory diagnosis of the antiphospholipid syndrome: a plethora of obstacles to overcome. Eur. J. Haematol. 83, 1\u201316 (2009).","journal-title":"Eur. J. Haematol."},{"key":"3012_CR16","doi-asserted-by":"publisher","first-page":"107602962311834","DOI":"10.1177\/10760296231183427","volume":"29","author":"B Smit","year":"2023","unstructured":"Smit, B. et al. Routine lupus anticoagulant sensitive aPTT testing can prevent unnecessary LA testing. Clin. Appl. Thromb. Hemost. 29, 10760296231183427 (2023).","journal-title":"Clin. Appl. Thromb. Hemost."},{"key":"3012_CR17","doi-asserted-by":"publisher","DOI":"10.1093\/jalm\/jfaf039","author":"J Wang","year":"2025","unstructured":"Wang, J., Leger, R., Chen, D. & Seheult, J. Enhancing lupus anticoagulant testing with machine learning: deep neural networks match expert performance without the need for feature selection. J. Appl. Lab. Med. https:\/\/doi.org\/10.1093\/jalm\/jfaf039 (2025).","journal-title":"J. Appl. Lab. Med."},{"key":"3012_CR18","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1182\/blood-2007-12-129627","volume":"113","author":"B Giannakopoulos","year":"2009","unstructured":"Giannakopoulos, B., Passam, F., Ioannou, Y. & Krilis, S. A. How we diagnose the antiphospholipid syndrome. Blood 113, 985\u2013994 (2009).","journal-title":"Blood"},{"key":"3012_CR19","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1046\/j.1365-2141.2000.02069.x","volume":"109","author":"M Greaves","year":"2000","unstructured":"Greaves, M. et al. Guidelines on the investigation and management of the antiphospholipid syndrome. Br. J. Haematol. 109, 704\u2013715 (2000).","journal-title":"Br. J. Haematol."},{"key":"3012_CR20","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1002\/acr.24520","volume":"73","author":"M Barbhaiya","year":"2021","unstructured":"Barbhaiya, M. et al. Development of new international antiphospholipid syndrome classification criteria Phase I\/II report: generation and reduction of candidate criteria. Arthritis Care Res. 73, 1490\u20131501 (2021).","journal-title":"Arthritis Care Res."},{"key":"3012_CR21","doi-asserted-by":"publisher","first-page":"2717","DOI":"10.1182\/blood-2002-11-3334","volume":"102","author":"M Galli","year":"2003","unstructured":"Galli, M., Luciani, D., Bertolini, G. & Barbui, T. Anti-beta 2-glycoprotein I, antiprothrombin antibodies, and the risk of thrombosis in the antiphospholipid syndrome. Blood 102, 2717\u20132723 (2003).","journal-title":"Blood"},{"key":"3012_CR22","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1111\/jth.15585","volume":"20","author":"A Vandevelde","year":"2022","unstructured":"Vandevelde, A. et al. Semiquantitative interpretation of anticardiolipin and anti-\u03b22-glycoprotein I antibodies measured with various analytical platforms: communication from the ISTH SSC Subcommittee on Lupus Anticoagulant\/Antiphospholipid Antibodies. J. Thromb. Haemost. 20, 508\u2013524 (2022).","journal-title":"J. Thromb. Haemost."},{"key":"3012_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2017.103","volume":"4","author":"K Schreiber","year":"2018","unstructured":"Schreiber, K. et al. Antiphospholipid syndrome. Nat. Rev. Dis. Primers 4, 17103 (2018).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"3012_CR24","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1055\/s-0036-1592336","volume":"42","author":"K Schreiber","year":"2016","unstructured":"Schreiber, K. et al. Pregnancy and antiphospholipid syndrome. Semin. Thromb. Hemost. 42, 780\u2013788 (2016).","journal-title":"Semin. Thromb. Hemost."},{"key":"3012_CR25","doi-asserted-by":"publisher","first-page":"8411","DOI":"10.3390\/ijms21218411","volume":"21","author":"R Misasi","year":"2020","unstructured":"Misasi, R. et al. Molecular mechanisms of \u201cantiphospholipid antibodies\u201d and their paradoxical role in the pathogenesis of \u201cseronegative APS. Int. J. Mol. Sci. 21, 8411 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"3012_CR26","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1160\/TH04-12-0839","volume":"93","author":"V Pengo","year":"2005","unstructured":"Pengo, V., Biasiolo, A., Pegoraro, C., Cucchini, U., Noventa, F. & Iliceto, S. Antibody profiles for the diagnosis of antiphospholipid syndrome. Thromb. Haemost. 93, 1147\u20131152 (2005).","journal-title":"Thromb. Haemost."},{"key":"3012_CR27","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1111\/jth.14633","volume":"18","author":"W Chayoua","year":"2020","unstructured":"Chayoua, W. et al. The (non-)sense of detecting anti-cardiolipin and anti-\u03b22-glycoprotein I IgM antibodies in the antiphospholipid syndrome. J. Thromb. Haemost. 18, 169\u2013179 (2020).","journal-title":"J. Thromb. Haemost."},{"key":"3012_CR28","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1111\/jth.13379","volume":"14","author":"H Kelchtermans","year":"2016","unstructured":"Kelchtermans, H., Pelkmans, L., de Laat, B. & Devreese, K. M. IgG\/IgM antiphospholipid antibodies present in the classification criteria for the antiphospholipid syndrome: a critical review of their association with thrombosis. J. Thromb. Haemost. 14, 1530\u20131548 (2016).","journal-title":"J. Thromb. Haemost."}],"container-title":["npj Digital Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41746-026-03012-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41746-026-03012-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41746-026-03012-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T12:10:57Z","timestamp":1791288657000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41746-026-03012-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,25]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3012"],"URL":"https:\/\/doi.org\/10.1038\/s41746-026-03012-7","relation":{},"ISSN":["2398-6352"],"issn-type":[{"value":"2398-6352","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,25]]},"assertion":[{"value":"28 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare the following competing interests: B.Z.K., K.K., Y.A., and M.S. are listed as inventors on a provisional patent application (63\/941,732) related to the diagnostic approach described in this study (Machine learning-based lupus anticoagulant prediction system and method). The patent is owned by Tel Aviv Sourasky Medical Center and Tel Aviv University. No licensing agreements, royalties, or commercial arrangements are currently in place. All other authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"765"}}